This webinar will cover an overview of the unique physiological mechanisms of nasal high flow therapy in paediatrics.
Webinar Series
This webinar is the second in a series on Nasal High Flow Therapy brought to you through a collaboration between Critical Care Education and Fisher & Paykel Healthcare. Your webinar host Ken Hambrecht will be joined by educators from Fisher & Paykel Healthcare to bring you the latest evidence and clinical application of Nasal High Flow Therapy in various hospital areas.
About this Webinar
This webinar will cover an overview of the unique physiological mechanisms of nasal high flow therapy in paediatrics. We also review the extensive clinical evidence supporting the efficacy of its use in this patient group.
High flow therapy has emerged as a new method of respiratory support for respiratory diseases in neonates and children. We discuss this therapy with a focus on how high flow and humidification physiologically supports the respiratory system due to the combination of mechanisms in action. We discuss identification of those infants who respond to the therapy, how to minimise the delay in utilising the therapy to minimise treatment failure and review its safety.
Key topics covered:
- The principles of humidification and gas conditioning in the immature airway
- Mechanisms of high flow in paediatrics
- Patient selection – responders vs non-responders
- Early application improves success
- Safety of the therapy
Other Webinars in this Series
Webinar 1: Nasal High Flow Therapy – Physiological Mechanisms
Presented by
In collaboration with
This webinar is sponsored by Fisher & Paykel Healthcare.
